Gensaic

Gensaic, Inc. is an editable genome therapeutics company spun out from MIT. Gensaic is pioneering a new class of gene delivery vehicles called Gene-Encoded Nanoparticles (GeNPs). Gensaic's first GeNP vehicle is premised on the evolution of M13 phage-derived particles (PDPs), a highly modular system consisting of three designable coats and a designed minimal phage DNA (mpDNA) cargo.